Project Details

Description

Circulating Tumor Cell-Based Patient-Derived Xenograft Models of Metastatic Bladder Cancer as a Platform for Development of Novel Therapeutic Approac

StatusFinished
Effective start/end date1/08/1731/07/19

Funding

  • U.S. Army: $673,356.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.